United States · Funded startup

Who invested in Atom Bioworks

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$999Kraised across 1 round since 2022, from 1 source

Latest round
Grant, $999KJul 2022
Investors
3
See who backed them

The rounds

  1. Jul 2022

Founders and team

From Atom Bioworks's own website: 1 founder.

Sherwood YaoCo-founder, CEO · Executive

AdvisersKeith Fraser

Everyone who backed them

Y CombinatorAccelerator1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Atom Bioworks as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

BioTools InnovatorAcceleratorPer its own site
MAGNET Venture CapitalVC firmPer its own site
Ms2 CapitalFamily officePer its own site

Quick answers about Atom Bioworks

Who invested in Atom Bioworks?

Atom Bioworks's investors include Y Combinator, National Science Foundation and National Institutes of Health.

How much has Atom Bioworks raised?

Atom Bioworks has raised $999K across 1 round since 2022.

When did Atom Bioworks last raise?

Atom Bioworks's most recent round was a Grant of $999K in Jul 2022.

What was Atom Bioworks's biggest round?

Its most recent round, $999K in Jul 2022, is also its largest on record.

Who backed Atom Bioworks first?

Atom Bioworks's first round on record, in Jul 2022, was backed by Y Combinator, National Science Foundation and National Institutes of Health.

What stage is Atom Bioworks at?

Atom Bioworks's latest named round is a Grant, in Jul 2022.

Where is Atom Bioworks based?

Atom Bioworks is based in the United States.

Companies like Atom Bioworks

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.